AzTrials
AzTrials

Prevalence of Airway ClosureAOP-VENTNCT07512713

Abbreviated Title: Airway Opening Pressure in Mechanically VENTilated Patients

An observational study of Prevalence of Airway Closure and in Adults in Intensive Care, run by University Hospital, Clermont-Ferrand at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Context: Mechanical ventilation is an essential treatment for patients admitted to intensive care. It is estimated that approximately 50% of adult patients admitted to intensive care require invasive mechanical ventilation. Read more about this study

Who is it for?
Ages 18 years and older
How many people
500 participants
Where
1 siteFrance
Study dates
May 2026to Feb 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Eligible patients will be prospectively included over a period of two weeks (14 consecutive days) in 38 intensive care units in France.

Who may be able to join

  • Age ≥ 18 years old
  • Patients admitted to a participating ICU
  • Patients receiving invasively ventilation for any cause We will only include patients under controlled mechanical ventilation because airway closure is difficult to assess in spontaneously breathing patients.
  • Non-inclusion Criteria:
  • A patient admitted to hospital or transferred to the intensive care unit without a documented time of intubation
  • Have a tracheotomy/tracheostomy at the time of inclusion
Show all 10Show fewer
  • Are receiving an assist ventilation mode
  • Patient or relative's refusal to participate for data collection
  • Pregnant or breast-feeding women
  • Legal protection (i.e., patient under a tutelage, or curatorship, or placed under judicial incarceration)

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • CHU de Clermont-Ferrand

    Clermont-Ferrand

    Lise LACLAUTRE, promo_interne_drci@chu-clermontferrand.fr

    pierre COUHAULT

Other trials in France

About this study

Official title: Assessment of Airway Opening Pressure in Critically Ill Adults Receiving Mechanical Ventilation: a Multicenter Prospective Observational Cohort Study

Context:

Mechanical ventilation is an essential treatment for patients admitted to intensive care. It is estimated that approximately 50% of adult patients admitted to intensive care require invasive mechanical ventilation. However, inappropriate ventilator settings expose patients to the risk of ventilator-induced lung injury (VILI). In particular, the cyclical opening and closing of the alveolar units can damage lung tissue and trigger an inflammatory response.

Read more

Measuring and monitoring airway pressure (Paw), particularly plateau pressure (Pplat) and driving pressure (DP), is essential in order to adjust ventilator settings and is the subject of international recommendations.

However, these static pressures may not accurately reflect alveolar pressure. Partial or complete closure of the airways can influence the measurement of Pplat and DP. Airway closure corresponds to an interruption in communication between the proximal airways and the alveoli when airway pressure is below the airway opening pressure (AOP) threshold (airway opening pressure or AOP). In the event of such closure, insufflation only begins when the airway pressure reaches this critical threshold. Consequently, in the event of airway closure, the airway pressure may differ from the alveolar pressure and thus distort the assessment of respiratory mechanics. Furthermore, when positive end-expiratory pressure (PEEP) is set below the critical AOP threshold, cyclic opening and closure of the alveolar units may occur, potentially contributing to VILI.Detection of airway closure and measurement of the corresponding AOP can be performed at the patient's bedside by simply examining the ventilator curves during slow-flow insufflation or by measuring conductive pressure. Despite the potential implications of airway closure for the assessment of respiratory mechanics in mechanically ventilated patients, its prevalence is not defined. It has been reported that this phenomenon may affect 20 to 50% of patients with acute respiratory distress syndrome (ARDS). It has also been suggested that this phenomenon may affect obese patients, asthmatic patients, or patients receiving insufficient PEEP.

Objectives:

The main objective of this multicentre observational study is to assess the prevalence of airway closure in a large population of adults in intensive care receiving invasive mechanical ventilation.

Type of study:

Multicentre observational cohort study

Number of centres:

39 intensive care units

Study procedure:

Phase 1: Identification and registration of participating centres Phase 2: Implementation of the study and data collection All patients undergoing invasive mechanical ventilation in controlled mode will undergo AOP measurement (analysis of the Paw curve during slow-flow insufflation according to standard clinical practice) between 8am and 10am on the day of inclusion, by a doctor other than the one in charge of the patient.

No changes will be made to the initial ventilator settings. The data will be collected anonymously on an eCRF. A standardised protocol for measuring AOP will be provided. The measurement will be repeated at H+12 alongside the collection of the usual ventilatory mechanics and oxygenation data (compliance, driving pressure, Pplat, mechanical power, PaO2/FiO2).

Phase 3: management and analysis of pseudonymised data

Read the detailed description

Eligible patients will be included prospectively over a period of two weeks (14 consecutive days); the two-week period will be left to the discretion of each intensive care unit participating in the research (within a total 'window' of two months). Any patient admitted to intensive care requiring invasive mechanical ventilation in controlled mode for the condition for which they were admitted will undergo AOP measurement (analysis of the Paw curve during slow-flow insufflation according to standard practice) between 8am and 10am on the day of inclusion, by a doctor other than the one in charge of the patient.No changes will be made to the initial ventilator settings. The data will be collated pseudonymously on an eCRF. A standardised protocol for measuring AOP will be provided. The measurement will be repeated at H12 alongside the collection of the usual ventilatory mechanics and oxygenation data (compliance, driving pressure, Pplat, mechanical power, PaO2/FiO2).

For newly admitted patients (ventilation duration < 24 hours), in participating centres that accept it, data will be collected upon discharge from intensive care or on day 28, whichever comes first, in order to gather the following prognostic information: total duration of mechanical ventilation up to day 28, time to weaning from ventilation, number of days alive without invasive ventilation support on day 28, mortality on day 28.

Keywords
airway closure AOP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome is the proportion of critically ill receiving mechanically ventilated patients with complete airway closure (AOP higher than PEEP).

    Complete airway closure and corresponding AOP will be identified on the pressure-time curve of the ventilator using a low-flow inflation (5 L/min, respiratory rate 5/min, tidal volume 6 mL/kg predicted body weight) after a prolonged exhalation to PEEP 5 cmH2O in volume-controlled mode.

    Measured: Data collection will be done twice (12-hour intervals) on the day of enrollment in the study. For newly admitted patients to participating ICUs, data collection will be done at day 1 and day 2.

Secondary outcomes (9)
  1. Mechanical power (MP)

    MP will be calculated by the following equation15: MP (J/min) = 0.098 × VT × RR × [PEEP + (0.5 × DP) + (Ppeak - Pplat)], where VT is tidal volume, RR respiratory rate, DP Driving Pressure, Ppeak peak airway pressure and Pplat plateau airway pressure.

    Measured: At day 1 and day 2 (if inclusion criteria are met)

  2. Mechanical power, computed using AOP instead total PEEP

    In patients with airway closure and AOP greater than PEEP

    Measured: At day 1 and day 2

  3. Conductive pressure (Pcond) and resistive pressure (Pres)

    Pcond and Pres will be identified on the pressure-time curve in volume-controlled mode using the initially set flow rate and then using using constant-flow of 50, 60 and 70 L/min.

    AOP will be calculated by the following equation: AOP = PEEP + (Pcond - Pres)

    Measured: From the ventilator at day 1 and day 2

  4. Driving pressure of the respiratory system (DPrs)

    computed as Pplat - PEEP, Driving pressure computed using AOP instead of PEEP (in patients with airway closure and AOP greater than PEEP)

    Measured: At day 1 and day 2

  5. Total duration to first separation attempt

    Number of days until the first attempt at separation (spontaneous breathing trial or direct extubation)

    Measured: Upon discharge from intensive care or on day 28

  6. Total duration to successful weaning from the ventilator,

    Defined as extubation followed by 48 hours of spontaneous breathing without mechanical ventilation.

    Measured: Upon discharge from intensive care or on day 28

  7. Total duration of ventilation

    Total duration of ventilation to ICU discharge or day 28, whichever comes first

    Measured: Upon discharge from intensive care or on day 28

  8. Days alive and off the ventilator

    Days alive and off the ventilator at ICU discharge or day 28, whichever comes first

    Measured: Upon discharge from intensive care or on day 28

  9. Reintubation (y/n)

    Reintubation (y/n) at ICU discharge or day 28, whichever comes first

    Measured: Upon discharge from intensive care or on day 28

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2026
  2. Study startMay 2026 (estimated)
  3. Primary completionFeb 2028 (estimated)
  4. Study completionFeb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07512713
Sponsor's protocol ID
RNI 2025 COUHAULT (AOP-VENT)
Other IDs
ANSM
Acronym
AOP-VENT
Status last verified
Dec 2025
First submitted
27 Mar 2026
Last updated
6 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Prevalence of Airway Closure and in Adults in Intensive Care, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lise LACLAUTRE (+33 473 754 963, promo_interne_drci@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome is the proportion of critically ill receiving mechanically ventilated patients with complete airway closure (AOP higher than PEEP). (time frame: Data collection will be done twice (12-hour intervals) on the day of enrollment in the study. For newly admitted patients to participating ICUs, data collection will be done at day 1 and day 2.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in